Analysis: Kenvue Inc.

US:KVUE

Why is Kenvue Inc. stock rising?

  • Listerine Clinical Solutions will be rolled out outside the US and a new US sensitivity variant will launch in Q2 2025.
  • Tylenol Precise Nighttime is being added to the Tylenol Precise lineup as a Self Care product extension.
  • New Skin Health products are planned for fall 2025 as part of the US Skin Health turnaround.

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Kenvue Inc. and 4,900+ companies.

Sign in
5-day free pass. No card required.